Biomarin Pharmaceutical (BMRN) Property, Plant & Equipment (Net) Growth (1y) (2010 - 2026)
Biomarin Pharmaceutical (BMRN) Property, Plant & Equipment (Net) Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 58.66% |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | -10.19% |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 2.65% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 24.11% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 12.18% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | -95.71% |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Biomarin Pharmaceutical | 11.65 Bn | 9.42 Bn | 571.21 Mn | -7.22% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.22% |
| Dec 31, 2025 | -8.68% |
| Sep 30, 2025 | -0.69% |
| Jun 30, 2025 | -2.14% |
| Mar 31, 2025 | -2.62% |
| Dec 31, 2024 | -2.17% |
| Sep 30, 2024 | -2.04% |
| Jun 30, 2024 | -1.35% |
| Mar 31, 2024 | -0.72% |
| Dec 31, 2023 | -0.67% |
| Sep 30, 2023 | 1.46% |
| Jun 30, 2023 | 1.70% |
| Mar 31, 2023 | 2.75% |
| Dec 31, 2022 | 3.66% |
| Sep 30, 2022 | 2.64% |
| Jun 30, 2022 | 2.23% |
| Mar 31, 2022 | 1.67% |
| Dec 31, 2021 | 0.29% |
| Sep 30, 2021 | 0.96% |
| Jun 30, 2021 | 1.55% |